289 related articles for article (PubMed ID: 16228287)
1. Enhanced nuclear factor-kappa B-associated Wnt-1 expression in hepatitis B- and C-related hepatocarcinogenesis: identification by functional proteomics.
Lee TH; Tai DI; Cheng CJ; Sun CS; Lin CY; Sheu MJ; Lee WP; Peng CY; Wang AH; Tsai SL
J Biomed Sci; 2006 Jan; 13(1):27-39. PubMed ID: 16228287
[TBL] [Abstract][Full Text] [Related]
2. Constitutive activation of nuclear factor kappaB in hepatocellular carcinoma.
Tai DI; Tsai SL; Chang YH; Huang SN; Chen TC; Chang KS; Liaw YF
Cancer; 2000 Dec; 89(11):2274-81. PubMed ID: 11147598
[TBL] [Abstract][Full Text] [Related]
3. Activation of nuclear factor kappaB in hepatitis C virus infection: implications for pathogenesis and hepatocarcinogenesis.
Tai DI; Tsai SL; Chen YM; Chuang YL; Peng CY; Sheen IS; Yeh CT; Chang KS; Huang SN; Kuo GC; Liaw YF
Hepatology; 2000 Mar; 31(3):656-64. PubMed ID: 10706556
[TBL] [Abstract][Full Text] [Related]
4. Wnt-1 protein as a prognostic biomarker for hepatitis B-related and hepatitis C-related hepatocellular carcinoma after surgery.
Lee HH; Uen YH; Tian YF; Sun CS; Sheu MJ; Kuo HT; Koay LB; Lin CY; Tzeng CC; Cheng CJ; Tang LY; Tsai SL; Wang AH
Cancer Epidemiol Biomarkers Prev; 2009 May; 18(5):1562-9. PubMed ID: 19423534
[TBL] [Abstract][Full Text] [Related]
5. Hepatic expression of the proliferative marker Ki-67 and p53 protein in HBV or HCV cirrhosis in relation to dysplastic liver cell changes and hepatocellular carcinoma.
Koskinas J; Petraki K; Kavantzas N; Rapti I; Kountouras D; Hadziyannis S
J Viral Hepat; 2005 Nov; 12(6):635-41. PubMed ID: 16255765
[TBL] [Abstract][Full Text] [Related]
6. Integration of the hepatitis B virus X fragment in hepatocellular carcinoma and its effects on the expression of multiple molecules: a key to the cell cycle and apoptosis.
Peng Z; Zhang Y; Gu W; Wang Z; Li D; Zhang F; Qiu G; Xie K
Int J Oncol; 2005 Feb; 26(2):467-73. PubMed ID: 15645132
[TBL] [Abstract][Full Text] [Related]
7. Different expression of apoptotic proteins between HBV-infected and non-HBV-infected hepatocellular carcinoma.
Chang CS; Huang SM; Lin HH; Wu CC; Wang CJ
Hepatogastroenterology; 2007; 54(79):2061-8. PubMed ID: 18251160
[TBL] [Abstract][Full Text] [Related]
8. Hepatocarcinogenesis: hepatitis viruses and altered tumor suppressor gene function.
Tabor E
Princess Takamatsu Symp; 1995; 25():151-61. PubMed ID: 8875620
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of nuclear factor-kappaB, urokinase-type plasminogen activator, and HBx and their clinicopathological significance in hepatocellular carcinoma.
Chan CF; Yau TO; Jin DY; Wong CM; Fan ST; Ng IO
Clin Cancer Res; 2004 Jun; 10(12 Pt 1):4140-9. PubMed ID: 15217951
[TBL] [Abstract][Full Text] [Related]
10. Alpha-fetoprotein as a tumor marker in hepatocellular carcinoma: investigations in south Indian subjects with hepatotropic virus and aflatoxin etiologies.
Murugavel KG; Mathews S; Jayanthi V; Shankar EM; Hari R; Surendran R; Vengatesan A; Raghuram K; Rajasambandam P; Murali A; Srinivas U; Palaniswamy KR; Pugazhendhi T; Thyagarajan SP
Int J Infect Dis; 2008 Nov; 12(6):e71-6. PubMed ID: 18658001
[TBL] [Abstract][Full Text] [Related]
11. Comparative analysis of HBV and HCV infection in hepatocellular carcinoma and chronic liver disease--an autopsy based study.
Vaiphei K; Pal NS; Arora SK
Indian J Pathol Microbiol; 2006 Jul; 49(3):357-61. PubMed ID: 17001884
[TBL] [Abstract][Full Text] [Related]
12. Induction of high-molecular-weight (HMW) tumor necrosis factor(TNF) alpha by hepatitis C virus (HCV) non-structural protein 3 (NS3) in liver cells is AP-1 and NF-kappaB-dependent activation.
Hassan M; Selimovic D; Ghozlan H; Abdel-Kader O
Cell Signal; 2007 Feb; 19(2):301-11. PubMed ID: 16916598
[TBL] [Abstract][Full Text] [Related]
13. Hepatitis C virus core protein promotes proliferation of human hepatoma cells through enhancement of transforming growth factor alpha expression via activation of nuclear factor-kappaB.
Sato Y; Kato J; Takimoto R; Takada K; Kawano Y; Miyanishi K; Kobune M; Sato Y; Takayama T; Matunaga T; Niitsu Y
Gut; 2006 Dec; 55(12):1801-8. PubMed ID: 16581947
[TBL] [Abstract][Full Text] [Related]
14. Characteristics of hepatic nuclear-transcription factor-kappa B expression and quantitative analysis in rat hepatocarcinogenesis.
Wu W; Yao DF; Qiu LW; Sai WL; Shen JJ; Yu HB; Wu XH; Li YM; Wang YL; Gu WJ
Hepatobiliary Pancreat Dis Int; 2009 Oct; 8(5):504-9. PubMed ID: 19822494
[TBL] [Abstract][Full Text] [Related]
15. [The effects of p16 and Rb protein expression and NF-kappaB activity on hepatocarcinogenesis].
Wang ZW; Peng ZH; Tang HM; Qiu GQ; Xing TH; Yang MZ
Zhonghua Yi Xue Za Zhi; 2004 Feb; 84(3):225-8. PubMed ID: 15059540
[TBL] [Abstract][Full Text] [Related]
16. Impact of occult hepatitis B virus infection and prior hepatitis B virus infection on development of hepatocellular carcinoma in patients with liver cirrhosis due to hepatitis C virus.
Adachi S; Shibuya A; Miura Y; Takeuchi A; Nakazawa T; Saigenji K
Scand J Gastroenterol; 2008; 43(7):849-56. PubMed ID: 18584524
[TBL] [Abstract][Full Text] [Related]
17. Nuclear factor-kappa B in the liver of patients with chronic hepatitis C: decreased RelA expression is associated with enhanced fibrosis progression.
Boya P; Larrea E; Sola I; Majano PL; Jiménez C; Civeira MP; Prieto J
Hepatology; 2001 Nov; 34(5):1041-8. PubMed ID: 11679977
[TBL] [Abstract][Full Text] [Related]
18. [Expression characteristics of nuclear factor kappa B in hepatocellular carcinoma tissues].
Zhou WM; Ping JL; Qian FC; Zhang GL
Zhonghua Gan Zang Bing Za Zhi; 2009 Nov; 17(11):843-6. PubMed ID: 19958645
[TBL] [Abstract][Full Text] [Related]
19. Hepatitis C virus-induced up-regulation of microRNA-155 promotes hepatocarcinogenesis by activating Wnt signaling.
Zhang Y; Wei W; Cheng N; Wang K; Li B; Jiang X; Sun S
Hepatology; 2012 Nov; 56(5):1631-40. PubMed ID: 22610915
[TBL] [Abstract][Full Text] [Related]
20. Activation of intracellular signaling by hepatitis B and C viruses: C-viral core is the most potent signal inducer.
Kato N; Yoshida H; Ono-Nita SK; Kato J; Goto T; Otsuka M; Lan K; Matsushima K; Shiratori Y; Omata M
Hepatology; 2000 Aug; 32(2):405-12. PubMed ID: 10915750
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
